AstraZeneca has pledged USD$10 million to help fund 50 new American Cancer Society Patient Navigator Program sites over the next five years in communities throughout the United States. The Patient Navigator Program is an initiative to assist individual cancer patients in negotiating the health care system.
The Australian Parliamentary Secretary to the Treasurer, Chris Pearce, today warned about the dangers associated with wearing non-prescription cosmetic contact lenses.
Doctors are still denying older people the sorts of tests and treatment they would offer to younger patients, reveals a survey in Quality and Safety in Health Care.
The Food and Drug Administration (FDA) is notifying health care providers and consumers about 28 post-marketing reports of intussusception following administration of Rotavirus, Live, Oral, Pentavalent vaccine (trade name RotaTeq), manufactured by Merck and Co., Inc.
Leading players in the mobile phone industry and the U.S. Government have joined forces to fight HIV/AIDS and other health challenges in 10 African countries.
Clinicians should carefully weigh the risks and benefits of when to administer platelet glycoprotein IIb/IIIa (Gp IIb/IIIa) inhibitors for patients with acute coronary syndromes undergoing invasive treatment, according to a study in the February 14 issue of JAMA.
People from lower socioeconomic backgrounds who suffer a heart attack come to the emergency department more often, are less likely to be treated aggressively and have higher mortality rates a year after the attack, says new University of Alberta research that has important implications for access to cardiac care.
Expenditures for the uninsured in Maryland totaled $1.47 billion in FY2002, according to an analysis conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.
People who have multiple sclerosis (MS) for 10 years and have few of the disabling symptoms of the disease are often told they have “benign MS” and that their symptoms will likely not ever occur to the same extent as other people with MS.
The Food and Drug Administration (FDA) today announced revisions to the labeling for the antibiotic Ketek (telithromycin) designed to improve the safe use of Ketek by patients.